The Time Interval From Induction to Delivery: All Participants
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 20.97 | 10.27 |
| Misoprostol and Foley Bulb Group | 16.27 | 7.6 |
Trial · Interventional
CompletedNot applicableResults postedRegistry dataThis trial does not test a peptide that PepBank tracks.
United States
1 trial · 1 completed · 1 with posted results
A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor
NCT02566005Sept 2015 to Jul 2016
Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.
A randomized, prospective trial will be offered to women admitted to the Roosevelt Hospital labor floor for labor induction. The hypothesis is that the simultaneous use of a foley bulb together with vaginal misoprostol will result in shorter induction to delivery time compared with vaginal misoprostol alone
Active comparator
misoprostol group
The women in the misoprostol only group will receive 25mcg of misoprostol per vagina every 4hours per the standard hospital protocol. Once the cervix becomes favorable or if the patient is in active labor, or if there is no progress for 24 hours, misoprostol administration will be discontinued. Further management of labor will depend on the labor team. (25mcg tablets are not available commercially; a 100mcg table is cut into fourths by the hospital pharmacist
Active comparator
misoprostol and foley bulb group
Women in the combination group will receive vaginal misoprostol per standard protocol. In addition, a foley bulb will be inserted digitally or by direct visualization with the use of a sterile speculum. The foley will be inserted through the internal os and filled with 60cc of normal saline. The catheter will be taped to the patient's inner thigh under gentle traction. When the foley bulb has fallen out (spontaneous expulsion), further management of labor depends on the labor team. If this does not occur, the catheter will be deflated and removed after 24 hours. Oxytocin will be initiated in those patients who were not in labor after expulsion or removal of the catheter.
Outcomes the sponsor listed as primary.
The Time Interval From Induction to Delivery: All Participants
Time frame · Day 1
During labor from the start of the induction to the delivery
Time (Hours) From Induction to Delivery: Nulliparous
Time frame · Day 1
Time (Hours) From Induction to Delivery: Multiparous
Time frame · Day 1
Time From Induction to Delivery: VD
Time frame · Day 1
Time (hours) from induction to delivery: Vaginal Delivery (VD)
Time From Induction to Delivery: CD
Time frame · Day 1
Time (hours) from induction to delivery: Cesarean Delivery (CD)
Per Treatment Protocol: Time (Hours) From Induction to Delivery
Time frame · day 1
The Time From Induction Until to Active Phase Labor
Time frame · Day 1
The Time From Active Phase to Delivery
Time frame · Day 1
Incidence of Chorioamnionitis
Time frame · Day 1
Incidence of Uterine Tachysystole
Time frame · Day 1
Incidence of Patient Discomfort
Time frame · Day 1
Estimated Blood Loss
Time frame · Day 1
Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 20.97 | 10.27 |
| Misoprostol and Foley Bulb Group | 16.27 | 7.6 |
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 22.7 | 10.58 |
| Misoprostol and Foley Bulb Group | 18.15 | 7.87 |
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 15.99 | 7.4 |
| Misoprostol and Foley Bulb Group | 11.89 | 4.6 |
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 18.87 | 8 |
| Misoprostol and Foley Bulb Group | 15.55 | 6.7 |
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 24.38 | 12.49 |
| Misoprostol and Foley Bulb Group | 17.95 | 9.29 |
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 20.5109 | 10.09 |
| Misoprostol and Foley Bulb Group | 16.6814 | 7.47 |
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 17.43 | 8.6 |
| Misoprostol and Foley Bulb Group | 12.81 | 5.83 |
| Group | Value (hours) | Spread |
|---|---|---|
| Misoprostol Group | 3.11 | 2.75 |
| Misoprostol and Foley Bulb Group | 3.76 | 3 |
| Group | Deaths | Serious events | Other events |
|---|---|---|---|
| Misoprostol Group25mcg of misoprostol per vagina every 4hours per the standard hospital protocol. Once the cervix becomes favorable or if the patient is in active labor, or if there is no progress for 24 hours, misoprostol administration will be discontinued. Further management of labor will depend on the labor team. (25mcg tablets are not available commercially; a 100mcg table is cut into fourths by the hospital pharmacist.) | 0 / 100 | 0 / 100 | 0 / 100 |
| Misoprostol and Foley Bulb Group25mcg of misoprostol per vagina every 4hours per the standard hospital protocol. In addition, a foley bulb will be inserted digitally or by direct visualization with the use of a sterile speculum. The foley will be inserted through the internal os and filled with 60cc of normal saline. The catheter will be taped to the patient's inner thigh under gentle traction. When the foley bulb has fallen out (spontaneous expulsion), further management of labor depends on the labor team. If this does not occur, the catheter will be deflated and removed after 24 hours. Oxytocin will be initiated in those patients who were not in labor after expulsion or removal of the catheter. | 0 / 100 | 0 / 100 | 0 / 100 |
Each cell reads participants affected / participants at risk, as the registry posted them.
Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works
Studies that cite this trial.
1 study on this page
Indexing hint: Systematic review · 2023
de Vaan et al. 2023The Cochrane database of systematic reviewscited by 38
PMID 36996264PMC10061553DOI 10.1002/14651858.cd001233.pub4PUB-36996264
References listed at the registry that are not in PepBank. They link to PubMed.
Who could join, as posted.
PepBank is a research reference. Talk to a doctor before you use any peptide.
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated